Delivery Order SPE2DB22D1202-SPE2DB25FVJX3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitive delivery order, with a ceiling value of $1,066.35 and firm fixed pricing, represents a continuation of the contractor's pharmaceutical supply services to federal military and healthcare systems. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order valued at $1,652.48 to AmerisourceBergen Drug Corp for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitively awarded, firm fixed-price contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cefpodoxime 200 mg tablets in quantities of 20 for a ceiling value of $1,949.17. This contract represents a non-set-aside, competitively awarded delivery order utilizing firm fixed pricing and is scheduled for completion by August 19, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,672.34 to AmerisourceBergen Drug Corp for Cefpodoxime 200 mg tablets in quantities of 20 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Cefpodoxime 200 mg Tablets. The $1,161.04 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- The Defense Logistics Agency awarded a $1,638.24 delivery order to AmerisourceBergen Drug Corp for Cefpodixome 200 mg tablets (20-count units) under a firm fixed-price contract, with an ultimate completion date of August 11, 2025. This award utilizes no set-aside designation and represents a competitive procurement for pharmaceutical supplies. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office headquarters. This delivery order...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,705.38 firm fixed-price contract is for the delivery of 4,567,914,247 units of the antibiotic cefpodoxime 200 mg tablets. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,853.45 fixed-price delivery order is for the supply of 4,568,097,185 units of the pharmaceutical drug Cefpodoxime 200 mg Tablet. The contract has a performance period through May 2, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,300,894 units of the prescription drug Cefpodoxime 100 mg tablets. The $5,808.14 firm fixed-price contract has a completion date of February 19, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,187,070 units of the pharmaceutical product Cefpodoxime 200mg 20s. The $1,456.56 contract has a performance completion date of December 27, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of supplying pharmaceuticals, medical supplies, and related...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVJX3Delivery Order
The Defense Logistics Agency awarded a $3,663.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for cefpodoxime 200 mg tablets (20-count) with a completion date of September 2, 2025. This contract is classified as a non-set-aside award, meaning it was competitively awarded without restrictions on eligible bidders. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations as a major pharmaceutical distributor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its critical role in supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with diverse pharmaceutical products across multiple therapeutic domains, positioning the company as a primary vendor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/29/25 |